Manufacturer copay assistance · Skyrizi IV (J2327) · AbbVie
Eligible patients pay as… · Maximum benefit Up to $14,000/year. Monthly maximums may apply. · Covers Skyrizi drug cost only — does NOT cover infusion administration or office visit fees
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
Run a benefits estimate for Skyrizi IV — the program's cap applies against the patient share CareCost calculates.
Yes — SKYRIZI Complete Savings Card from AbbVie. Eligible patients pay as little as $5 per dose ($12.65/treatment cap as of Jan 2026). Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Eligible patients pay as little as $5 per dose ($12.65/treatment cap as of Jan 2026) Maximum benefit: Up to $14,000/year. Monthly maximums may apply.. Covers Skyrizi drug cost only — does NOT cover infusion administration or office visit fees
Accepted insurance: commercial. Not eligible: medicare, medicaid, tricare, va, government.